Bleeding is a common problem in cancer patients, related to local tumor invasion, tumor
angiogenesis, systemic effects of the cancer, or anti-cancer treatments. Existing bleeds can …

Background: Palliative care was originally intended for patients with non-haematological
neoplasms and relatively few studies have assessed palliative care in patients with …

Objectives Home is considered the preferred place of death for many, but patients with
haematological malignancies (leukaemias, lymphomas and myeloma) die in hospital more …

Background and Objectives: Roughly 10% of cancer patients experience an episode of
bleeding. The bleeding severity can range from occasional trivial bleeds to major bleeding …

Abnormalities of hemostasis are frequently encountered in patients with hematologic
malignancies leading to both hemorrhagic and thrombotic adverse events. The prompt …

Background: Transfusion is not an exceptional circumstance in palliative cancer patients
(PCPs). This makes it necessary to confront not only medical aspects but also those of …

Palliative care emergencies are emergencies in patients with an incurable disease that may
lead to death or decreased quality of life. During the palliative care phase of a patient's life …

Objectives Current UK health policy promotes enabling people to die in a place they choose,
which for most is home. Despite this, patients with haematological malignancies …

Massive hemoptysis is one of emergency and critical diseases of the respiratory system. The
definition of massive hemoptysis has always been different in the literature, which often …

Background Accurate prognosticating is needed when patients are nearing the end of life to
ensure appropriate treatment decisions, and facilitate palliative care provision and …